Sensei Biotherapeutics Inc. (SNSE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sensei Biotherapeutics In...

    NASDAQ: SNSE · Real-Time Price · USD
    8.48
    -0.33 (-3.79%)
    At close: Sep 05, 2025, 12:41 PM

    Sensei Biotherapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 551K 571K 1.81M 685K
    Gross Profit
    		 -551K -571K -1.81M -685K
    Operating Income
    		 -32.61M -37.06M -50.19M -37.48M
    Interest Income
    		 2.55M 3.62M 1.78M 800K
    Pretax Income
    		 -30.16M -34.1M -48.59M -36.79M
    Net Income
    		 -30.16M -34.1M -48.81M -36.79M
    Selling & General & Admin
    		 13.04M 18.77M 19.8M 15.82M
    Research & Development
    		 18.63M 18.3M 30.38M 21.66M
    Other Expenses
    		 -551K -571K n/a n/a
    Operating Expenses
    		 31.11M 36.49M 50.19M 37.48M
    Interest Expense
    		 90K 144K 219K 670K
    Selling & Marketing Expenses
    		 n/a 100K n/a n/a
    Cost & Expenses
    		 31.66M 37.06M 50.19M 37.48M
    Income Tax Expense
    		 n/a n/a 219K 670K
    Shares Outstanding (Basic)
    		 25.12M 27.95M 30.7M 27.71M
    Shares Outstanding (Diluted)
    		 25.12M 27.95M 30.7M 27.71M
    EPS (Basic)
    		 -1.2 -1.22 -1.58 -1.33
    EPS (Diluted)
    		 -1.2 -1.22 -1.58 -1.33
    EBITDA
    		 -29.52M -33.39M -48.84M -35.44M
    EBIT
    		 -30.07M -36.96M -50.19M -36.12M
    Depreciation & Amortization
    		 551K 3.68M 1.35M 685K

    Add to Watchlist